FDA recall Z-0460-2022

Abbott Molecular, Inc. · Class II · device

Product

Alinity m System, Part No. 08N53-002

Reason for recall

There is a potential for abnormal (non-sigmoidal) amplification curves.

Distribution

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Cambodia, Canada, Chile, Colombia, Czech Republic, Egypt, El Salvador, Estonia, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Malawi, Malaysia, Mexico, Montenegro, Morocco, Mozambique, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Uganda, United Kingdom, and Vietnam.

Key facts

Status
Ongoing
Initiation date
2021-12-06
Report date
2022-01-12
Voluntary/Mandated
Voluntary: Firm initiated
Location
Des Plaines, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0460-2022